All case series and reports 151,152,153,154,155 reported better metabolic outcomes in patients with comorbid severe mental illness and diabetes and/or obesity who were concomitantly treated with antipsychotics and GLP-1RAs
It also helps in maintaining accurate patient records and tracking medication usage over time
The SURMOUNT-1 trial showed average weight loss of 20.2 percent at 72 weeks on the highest dose, a figure that stunned the medical community when it was first published
Neither is 'wrong'they just serve different purposes
Regular meetings help us keep track of any changes in your body weight and overall wellbeing, ensuring you remain focused on your goals
The demand shows no signs of slowing down, and as a result, counterfeit GLP-1 drugs are becoming an increasingly bigger piece of the landscapeso big, in fact, that the World Health Organization (WHO) last week issued a warning to people to be wary of the fake versions